{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:20:30Z","timestamp":1773271230845,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Clinical Trials from the Affiliated Drum Tower Hospital, Medical School of Nanjing University","award":["2022-LCYJ-PY-40"],"award-info":[{"award-number":["2022-LCYJ-PY-40"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s10067-026-07969-4","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T10:25:44Z","timestamp":1770373544000},"page":"2287-2295","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elevated serum MMP3 levels as a potential biomarker of disease activity in primary Sj\u00f6gren's syndrome: a prospective observational study"],"prefix":"10.1007","volume":"45","author":[{"given":"Kunzhan","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongling","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiye","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5249-8434","authenticated-orcid":false,"given":"Sen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"issue":"1","key":"7969_CR1","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M et al (2022) Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Exp Med 22(1):9\u201325. https:\/\/doi.org\/10.1007\/s10238-021-00728-6","journal-title":"Clin Exp Med"},{"issue":"9894","key":"7969_CR2","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S0140-6736(13)60954-X","volume":"382","author":"M Wahren-Herlenius","year":"2013","unstructured":"Wahren-Herlenius M, D\u00f6rner T (2013) Immunopathogenic mechanisms of systemic autoimmune disease. Lancet 382(9894):819\u2013831. https:\/\/doi.org\/10.1016\/S0140-6736(13)60954-X","journal-title":"Lancet"},{"issue":"12","key":"7969_CR3","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.55563\/clinexprheumatol\/vmqtz4","volume":"40","author":"J He","year":"2022","unstructured":"He J, Jiang J, Baumgart K (2022) Candidate autoantibodies for primary Sj\u00f6gren\u2019s syndrome: where are they now. Clin Exp Rheumatol 40(12):2387\u20132394. https:\/\/doi.org\/10.55563\/clinexprheumatol\/vmqtz4","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"7969_CR4","doi-asserted-by":"publisher","first-page":"2223","DOI":"10.1002\/art.22658","volume":"56","author":"C Vitali","year":"2007","unstructured":"Vitali C, Palombi G, Baldini C et al (2007) Sj\u00f6gren\u2019s Syndrome Disease Damage Index and disease activity index: scoring systems for the assessment of disease damage and disease activity in Sj\u00f6gren\u2019s syndrome, derived from an analysis of a cohort of Italian patients. Arthritis Rheum 56(7):2223\u20132231. https:\/\/doi.org\/10.1002\/art.22658","journal-title":"Arthritis Rheum"},{"issue":"6","key":"7969_CR5","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1136\/ard.2009.110619","volume":"69","author":"R Seror","year":"2010","unstructured":"Seror R, Ravaud P, Bowman SJ et al (2010) EULAR Sjogren\u2019s syndrome disease activity index: development of a consensus systemic disease activity index for primary Sjogren\u2019s syndrome. Ann Rheum Dis 69(6):1103\u20131109. https:\/\/doi.org\/10.1136\/ard.2009.110619","journal-title":"Ann Rheum Dis"},{"issue":"24","key":"7969_CR6","doi-asserted-by":"publisher","first-page":"7162","DOI":"10.1111\/febs.15701","volume":"288","author":"W Bassiouni","year":"2021","unstructured":"Bassiouni W, Ali M, Schulz R (2021) Multifunctional intracellular matrix metalloproteinases: implications in disease. FEBS J 288(24):7162\u20137182. https:\/\/doi.org\/10.1111\/febs.15701","journal-title":"FEBS J"},{"issue":"3","key":"7969_CR7","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1124\/pharmrev.121.000349","volume":"74","author":"L de Almeida","year":"2022","unstructured":"de Almeida L, Thode H, Eslambolchi Y et al (2022) Matrix Metalloproteinases: from molecular mechanisms to physiology, pathophysiology, and pharmacology. Pharmacol Rev 74(3):712\u2013768. https:\/\/doi.org\/10.1124\/pharmrev.121.000349","journal-title":"Pharmacol Rev"},{"issue":"1","key":"7969_CR8","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/j.1471-4159.2008.05399.x","volume":"106","author":"DH Choi","year":"2008","unstructured":"Choi DH, Kim EM, Son HJ et al (2008) A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J Neurochem 106(1):405\u2013415. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05399.x","journal-title":"J Neurochem"},{"issue":"1","key":"7969_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bbrc.2011.08.029","volume":"413","author":"J Yoo","year":"2011","unstructured":"Yoo J, Rodriguez Perez CE, Nie W, Sinnett-Smith J, Rozengurt E (2011) Protein kinase D1 mediates synergistic MMP-3 expression induced by TNF-\u03b1 and bradykinin in human colonic myofibroblasts. Biochem Biophys Res Commun 413(1):30\u201335. https:\/\/doi.org\/10.1016\/j.bbrc.2011.08.029","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"7969_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/ar3857","volume":"14","author":"DL Mattey","year":"2012","unstructured":"Mattey DL, Packham JC, Nixon NB et al (2012) Association of cytokine and matrix metalloproteinase profiles with disease activity and function in ankylosing spondylitis. Arthritis Res Ther 14(3):R127. https:\/\/doi.org\/10.1186\/ar3857","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"7969_CR11","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"CH Chen","year":"2006","unstructured":"Chen CH, Lin KC, Yu DT et al (2006) Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology (Oxford) 45(4):414\u2013420. https:\/\/doi.org\/10.1093\/rheumatology\/kei208","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7969_CR12","doi-asserted-by":"publisher","first-page":"15652","DOI":"10.4238\/2015.December.1.17","volume":"14","author":"MJ Ma","year":"2015","unstructured":"Ma MJ, Liu HC, Qu XQ, Wang JL (2015) Matrix metalloproteinase-3 gene polymorphism and its mRNA expression in rheumatoid arthritis. Genet Mol Res 14(4):15652\u201315659. https:\/\/doi.org\/10.4238\/2015.December.1.17","journal-title":"Genet Mol Res"},{"issue":"2","key":"7969_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1136\/annrheumdis-2014-206008","volume":"75","author":"R Seror","year":"2016","unstructured":"Seror R, Bootsma H, Saraux A et al (2016) Defining disease activity states and clinically meaningful improvement in primary Sj\u00f6gren\u2019s syndrome with EULAR primary Sj\u00f6gren\u2019s syndrome disease activity (ESSDAI) and patient-reported indexes (ESSPRI). Ann Rheum Dis 75(2):382\u2013389. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206008","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"7969_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/hed.26009","volume":"42","author":"A Miguel","year":"2020","unstructured":"Miguel A, Mello FW, Melo G, Rivero E (2020) Association between immunohistochemical expression of matrix metalloproteinases and metastasis in oral squamous cell carcinoma: systematic review and meta-analysis. Head Neck 42(3):569\u2013584. https:\/\/doi.org\/10.1002\/hed.26009","journal-title":"Head Neck"},{"issue":"9","key":"7969_CR15","doi-asserted-by":"publisher","first-page":"7363","DOI":"10.1002\/jcb.27040","volume":"119","author":"Y Okusha","year":"2018","unstructured":"Okusha Y, Eguchi T, Sogawa C et al (2018) The intranuclear PEX domain of MMP involves proliferation, migration, and metastasis of aggressive adenocarcinoma cells. J Cell Biochem 119(9):7363\u20137376. https:\/\/doi.org\/10.1002\/jcb.27040","journal-title":"J Cell Biochem"},{"key":"7969_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.939265","volume":"13","author":"Z Liang","year":"2022","unstructured":"Liang Z, Wang N, Shang L et al (2022) Evaluation of the immune feature of ACPA-negative rheumatoid arthritis and the clinical value of matrix metalloproteinase-3. Front Immunol 13:939265. https:\/\/doi.org\/10.3389\/fimmu.2022.939265","journal-title":"Front Immunol"},{"issue":"1\u20132","key":"7969_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jneuroim.2007.10.018","volume":"195","author":"FR Romi","year":"2008","unstructured":"Romi FR, Gilhus NE, Luckman SP (2008) Serum matrix metalloproteinase-3 levels are elevated in myasthenia gravis. J Neuroimmunol 195(1\u20132):96\u201399. https:\/\/doi.org\/10.1016\/j.jneuroim.2007.10.018","journal-title":"J Neuroimmunol"},{"issue":"1","key":"7969_CR18","doi-asserted-by":"publisher","first-page":"e007983","DOI":"10.1136\/jitc-2023-007983","volume":"12","author":"J Liu","year":"2024","unstructured":"Liu J, Chen H, Guo C et al (2024) Sulforaphane activates CD8(+) T cells antitumor response through IL-12RB2\/MMP3\/FasL-induced MDSCs apoptosis\u2019. J Immunother Cancer 12(1):e007983. https:\/\/doi.org\/10.1136\/jitc-2023-007983","journal-title":"J Immunother Cancer"},{"issue":"12","key":"7969_CR19","doi-asserted-by":"publisher","first-page":"6885","DOI":"10.1073\/pnas.96.12.6885","volume":"96","author":"M Wang","year":"1999","unstructured":"Wang M, Qin X, Mudgett JS, Ferguson TA, Senior RM, Welgus HG (1999) Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci U S A 96(12):6885\u20136889. https:\/\/doi.org\/10.1073\/pnas.96.12.6885","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"7969_CR20","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1093\/bjd\/ljae205","volume":"191","author":"C Dong","year":"2025","unstructured":"Dong C, Lin J, Lu X et al (2025) Fibroblasts with high matrix metalloproteinase 2 expression regulate C D8+ T-cell residency and inflammation via CD100 in psoriasis. Br J Dermatol 191(3):405\u2013418. https:\/\/doi.org\/10.1093\/bjd\/ljae205","journal-title":"Br J Dermatol"},{"key":"7969_CR21","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8483938","volume":"2021","author":"HK Pak","year":"2021","unstructured":"Pak HK, Kim YW, Nam B et al (2021) The migration of human follicular dendritic cell-like cell is facilitated by matrix metalloproteinase 3 expression that is mediated through TNF\u03b1-ERK1\/2-AP1 signaling. J Immunol Res 2021:8483938. https:\/\/doi.org\/10.1155\/2021\/8483938","journal-title":"J Immunol Res"},{"key":"7969_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1025377","volume":"13","author":"R Chunder","year":"2022","unstructured":"Chunder R, Schropp V, Jabari S, Marzin M, Amor S, Kuerten S (2022) Identification of a novel role for matrix metalloproteinase-3 in the modulation of B cell responses in multiple sclerosis. Front Immunol 13:1025377. https:\/\/doi.org\/10.3389\/fimmu.2022.1025377","journal-title":"Front Immunol"},{"issue":"6","key":"7969_CR23","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.semnephrol.2013.08.001","volume":"33","author":"M Noris","year":"2013","unstructured":"Noris M, Remuzzi G (2013) Overview of complement activation and regulation. Semin Nephrol 33(6):479\u2013492. https:\/\/doi.org\/10.1016\/j.semnephrol.2013.08.001","journal-title":"Semin Nephrol"},{"issue":"4","key":"7969_CR24","first-page":"409","volume":"16","author":"L Kotajima","year":"1998","unstructured":"Kotajima L, Aotsuka S, Fujimani M et al (1998) Increased levels of matrix metalloproteinase-3 in sera from patients with active lupus nephritis. Clin Exp Rheumatol 16(4):409\u2013415","journal-title":"Clin Exp Rheumatol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07969-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07969-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07969-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T08:21:34Z","timestamp":1773217294000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07969-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["7969"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07969-4","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u201cDeclaration of Helsinki\u201d were strictly observed throughout this prospective observational study. Approval was obtained from the Institutional Review Board of Nanjing Drum Tower Hospital, China (No. 2025\u20130481-01), and all participants provided written informed consent before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}